Pharmaceutical Industry Information Portal

HomeTagsBIOCAD

All posts by tag

BIOCAD

A Clinical Trial of a Russian Originator for the Treatment of Cervical Cancer Started in China

A joint venture between the biotechnology company BIOCAD and Shanghai Pharmaceuticals Holding has announced the enrollment of the first patient in a trial of...

The clinical trial for an original Russian lung cancer drug has started in China

The BIOCAD and Shanghai Pharmaceuticals Holding joint venture has announced the enrollment of the first Chinese patient in the Phase III international multicenter clinical trial...

А phase III study proven the efficacy of the bevacizumab biosimilar in patients with late stages of NSCLC

New results for Phase III study of BCD-021, a bevacizumab biosimilar, were presented as a poster at the European Society for Medical Oncology (ESMO)...

Russian Health Ministry permits Biocad to conduct clinical trials of new COVID vaccine

The state registry notes that the trials will last until late 2026 and will involve 360 patients. The vaccine will be administered via an intramuscular injection.

Russia to produce 90 mln anti-COVID-19 vaccine sets by October

We plan to hit the production figure of 30 million sets in July and this figure will be approximately the same for August and September, Manturov said.

BIOCAD has registered an original drug for the treatment of rheumatoid arthritis

The Ministry of Health of the Russian Federation has approved the original drug Levilimab (Russian trade name Ilsira) for the treatment of rheumatoid arthritis...
spot_img

Expert Articles

spot_img